These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 32240595)
21. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. Pinato DJ; Sharma R; Allara E; Yen C; Arizumi T; Kubota K; Bettinger D; Jang JW; Smirne C; Kim YW; Kudo M; Howell J; Ramaswami R; Burlone ME; Guerra V; Thimme R; Ishizuka M; Stebbing J; Pirisi M; Carr BI J Hepatol; 2017 Feb; 66(2):338-346. PubMed ID: 27677714 [TBL] [Abstract][Full Text] [Related]
22. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation. Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408 [No Abstract] [Full Text] [Related]
23. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection. Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565 [TBL] [Abstract][Full Text] [Related]
24. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria. Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612 [TBL] [Abstract][Full Text] [Related]
25. Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker. Hiraoka A; Kato M; Marui K; Murakami T; Onishi K; Adachi T; Matsuoka J; Ueki H; Yoshino T; Tsuruta M; Aibiki T; Okudaira T; Kuroda T; Iwasaki R; Suga Y; Miyata H; Ninomiya T; Hirooka M; Abe M; Matsuura B; Michitaka K; Hiasa Y Cancer Med; 2021 Jun; 10(11):3584-3592. PubMed ID: 33960691 [TBL] [Abstract][Full Text] [Related]
26. An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria. Ho SY; Liu PH; Hsu CY; Hsia CY; Su CW; Huang YH; Lei HJ; He YJ; Hou MC; Huo TI Am J Clin Oncol; 2019 Sep; 42(9):698-704. PubMed ID: 31335351 [TBL] [Abstract][Full Text] [Related]
27. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection. Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485 [TBL] [Abstract][Full Text] [Related]
28. Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC. Zhao S; Wang M; Yang Z; Tan K; Zheng D; Du X; Liu L Ann Transl Med; 2020 Apr; 8(8):539. PubMed ID: 32411762 [TBL] [Abstract][Full Text] [Related]
29. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma. Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748 [TBL] [Abstract][Full Text] [Related]
30. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection. Luo H; Li C; Chen L Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272 [TBL] [Abstract][Full Text] [Related]
31. Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC. Zhao S; Zhang T; Li H; Wang M; Xu K; Zheng D; Du X; Liu L Ann Transl Med; 2020 Apr; 8(8):538. PubMed ID: 32411761 [TBL] [Abstract][Full Text] [Related]
32. Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria. Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ World J Surg; 2018 Jun; 42(6):1841-1847. PubMed ID: 29138913 [TBL] [Abstract][Full Text] [Related]
33. The association of liver function and quality of life of patients with liver cancer. Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687 [TBL] [Abstract][Full Text] [Related]
34. Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review. Bannaga A; Arasaradnam RP World J Gastroenterol; 2020 Sep; 26(33):5022-5049. PubMed ID: 32952347 [TBL] [Abstract][Full Text] [Related]
35. Validation of the albumin-indocyanine green evaluation model in patients with resected hepatocellular carcinoma and comparison with the albumin-bilirubin score. Russolillo N; Forchino F; Conci S; Mele C; Langella S; Ruzzenente A; Scoleri I; Giuliante F; Guglielmi A; Ferrero A J Hepatobiliary Pancreat Sci; 2019 Jan; 26(1):51-57. PubMed ID: 30537424 [TBL] [Abstract][Full Text] [Related]
36. A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma. Shi JY; Sun LY; Quan B; Xing H; Li C; Liang L; Pawlik TM; Zhou YH; Wang H; Gu WM; Chen TH; Lau WY; Shen F; Wang NY; Yang T Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101534. PubMed ID: 33067168 [TBL] [Abstract][Full Text] [Related]
37. Role of Baseline Albumin-Bilirubin Grade on Predict Overall Survival Among Sorafenib-Treated Patients With Hepatocellular Carcinoma in Vietnam. Nguyen TTH; Nguyen VH; Nguyen VH; Nguyen TL; Le VQ Cancer Control; 2019; 26(1):1073274819865269. PubMed ID: 31364390 [TBL] [Abstract][Full Text] [Related]
38. Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use. Kuo YH; Wang JH; Hung CH; Rau KM; Wu IP; Chen CH; Kee KM; Hu TH; Lu SN J Gastroenterol Hepatol; 2017 Dec; 32(12):1975-1981. PubMed ID: 28295594 [TBL] [Abstract][Full Text] [Related]
39. Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization. Gui B; Weiner AA; Nosher J; Lu SE; Foltz GM; Hasan O; Kim SK; Gendel V; Mani NB; Carpizo DR; Saad NE; Kennedy TJ; Zuckerman DA; Olsen JR; Parikh PJ; Jabbour SK Am J Clin Oncol; 2018 Sep; 41(9):861-866. PubMed ID: 28418940 [TBL] [Abstract][Full Text] [Related]
40. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma. Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]